Evidenz
[1] Originalpublikation
Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Introduced the discriminant function combining prothrombin time and bilirubin; patients with a high value had substantial short-term mortality and appeared to benefit most from corticosteroids.
Gastroenterology, 1978
[2] Validierung
Carithers RL Jr, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. Used the modified discriminant function 4.6·(PT − control) + bilirubin with a threshold of 32 to define severe disease; corticosteroids reduced 28-day mortality in that group.
Annals of Internal Medicine, 1989
[3] Leitlinie
Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Uses the discriminant function and MELD to assess the severity of alcohol-associated hepatitis.
Hepatology, 2020
Zuletzt geprüft: 2026-10
Fehler in diesem Rechner melden